Israel’s Can-Fite BioPharma has announced positive results in its Phase IIb trial of their CF101 treatment for patients with active rheumatoid arthritis.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000903835&fid=1725
Success in treating rheumatoid arthritis
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.